Cargando…
Can rivaroxaban be a drug of choice for treating heparin-induced thrombocytopenia in a patient with pulmonary thromboembolism?
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Kare Publishing
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512203/ https://www.ncbi.nlm.nih.gov/pubmed/28680014 http://dx.doi.org/10.14744/AnatolJCardiol.2017.7805 |
| _version_ | 1783250459382775808 |
|---|---|
| author | Vavlukis, Marija Kotlar, Irina Taravari, Hajber Poposka, Lidija Kedev, Sasko |
| author_facet | Vavlukis, Marija Kotlar, Irina Taravari, Hajber Poposka, Lidija Kedev, Sasko |
| author_sort | Vavlukis, Marija |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5512203 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Kare Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-55122032017-07-27 Can rivaroxaban be a drug of choice for treating heparin-induced thrombocytopenia in a patient with pulmonary thromboembolism? Vavlukis, Marija Kotlar, Irina Taravari, Hajber Poposka, Lidija Kedev, Sasko Anatol J Cardiol Case Report Kare Publishing 2017-07 /pmc/articles/PMC5512203/ /pubmed/28680014 http://dx.doi.org/10.14744/AnatolJCardiol.2017.7805 Text en Copyright: © 2017 Turkish Society of Cardiology http://creativecommons.org/licenses/by-nc-sa/4.0 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License |
| spellingShingle | Case Report Vavlukis, Marija Kotlar, Irina Taravari, Hajber Poposka, Lidija Kedev, Sasko Can rivaroxaban be a drug of choice for treating heparin-induced thrombocytopenia in a patient with pulmonary thromboembolism? |
| title | Can rivaroxaban be a drug of choice for treating heparin-induced thrombocytopenia in a patient with pulmonary thromboembolism? |
| title_full | Can rivaroxaban be a drug of choice for treating heparin-induced thrombocytopenia in a patient with pulmonary thromboembolism? |
| title_fullStr | Can rivaroxaban be a drug of choice for treating heparin-induced thrombocytopenia in a patient with pulmonary thromboembolism? |
| title_full_unstemmed | Can rivaroxaban be a drug of choice for treating heparin-induced thrombocytopenia in a patient with pulmonary thromboembolism? |
| title_short | Can rivaroxaban be a drug of choice for treating heparin-induced thrombocytopenia in a patient with pulmonary thromboembolism? |
| title_sort | can rivaroxaban be a drug of choice for treating heparin-induced thrombocytopenia in a patient with pulmonary thromboembolism? |
| topic | Case Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512203/ https://www.ncbi.nlm.nih.gov/pubmed/28680014 http://dx.doi.org/10.14744/AnatolJCardiol.2017.7805 |
| work_keys_str_mv | AT vavlukismarija canrivaroxabanbeadrugofchoicefortreatingheparininducedthrombocytopeniainapatientwithpulmonarythromboembolism AT kotlaririna canrivaroxabanbeadrugofchoicefortreatingheparininducedthrombocytopeniainapatientwithpulmonarythromboembolism AT taravarihajber canrivaroxabanbeadrugofchoicefortreatingheparininducedthrombocytopeniainapatientwithpulmonarythromboembolism AT poposkalidija canrivaroxabanbeadrugofchoicefortreatingheparininducedthrombocytopeniainapatientwithpulmonarythromboembolism AT kedevsasko canrivaroxabanbeadrugofchoicefortreatingheparininducedthrombocytopeniainapatientwithpulmonarythromboembolism |